Cite
CRT-200.39 Comparisons of Two Different Platelet Glycoprotein IIb/IIIa Receptor Blockers Clotinab™ and ReoPro® in Patients With Acute Myocardial Infarction.
MLA
Lee, Min-Ho, et al. “CRT-200.39 Comparisons of Two Different Platelet Glycoprotein IIb/IIIa Receptor Blockers Clotinab™ and ReoPro® in Patients With Acute Myocardial Infarction.” JACC: Cardiovascular Interventions, vol. 9, Feb. 2016, pp. S14–15. EBSCOhost, https://doi.org/10.1016/j.jcin.2015.12.071.
APA
Lee, M.-H., Rha, S.-W., Park, B. W., Bang, D. W., Hyon, M. S., Choi, B. G., Park, S., Ahn, J., & Oh, D. J. (2016). CRT-200.39 Comparisons of Two Different Platelet Glycoprotein IIb/IIIa Receptor Blockers Clotinab™ and ReoPro® in Patients With Acute Myocardial Infarction. JACC: Cardiovascular Interventions, 9, S14–S15. https://doi.org/10.1016/j.jcin.2015.12.071
Chicago
Lee, Min-Ho, Seung-Woon Rha, Byung Won Park, Duk Won Bang, Min Su Hyon, Byoung Geol Choi, Sangho Park, Jihoon Ahn, and Dong Joo Oh. 2016. “CRT-200.39 Comparisons of Two Different Platelet Glycoprotein IIb/IIIa Receptor Blockers Clotinab™ and ReoPro® in Patients With Acute Myocardial Infarction.” JACC: Cardiovascular Interventions 9 (February): S14–15. doi:10.1016/j.jcin.2015.12.071.